Lymphedema and lymphatic disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All Subjects included in this study are lymphedema and lymphatic disease patients undergoing surgical treatment at our department who have been fully informed of all clinical tests, questionnaires, surgical treatments, and the purpose and analysis of this study and have all consented in writing. No age restriction and exclusion criteria were set.
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We analyze the assesment pre-operation and every 6 month. 1.Volume of chylous effusion and ascites | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient chart (name, patient ID, clinical history, pre and postoperative course, limb circumference, tissue stiffness); echogram(especially collecting lymphatic vessels), CT, MRI, lymphoscintigraphy, indocyanine green lymphography, and lymphoangiography obervations; blood test (complete blood count, chemistry, coagulation, blood type); histopathological analysis (collecting lymphatic vessel, adipose tissue, skin tissue, etc.); clinical photography (bilateral upper limbs for upper limb edema, bilateral lower limbs, abdominal, and inguinal area for lower limb lymphedema); health-related QOL analysis using Short Form (SF)-36 Health Survey; patient weight; general physical and image observations. | — |
Countries
Japan
Contacts
Saiseikai Kawaguchi General Hospital Financial and legal department